Haemorrhages and Thromboembolic Venous Disease of the Postpartum (HEMOTHEPP)

R

Regional University Hospital Center (CHRU)

Status

Completed

Conditions

Venous Thromboembolism
Postpartum Hemorrhage

Study type

Observational

Funder types

Other

Identifiers

NCT02443610
HEMOTHEPP ( RB 13.175)

Details and patient eligibility

About

The aim of this study is to evaluate the frequencey and the determinants of postpartum major complications (hemorrhage and thrombosis) up to 3 months after delivery in the maternity hospitals of Finistère (Bretagne - France)

Full description

This is an analytical observational prospective multicenter cohort study , conducted on all the maternity hospitals in Finistère (Bretagne - France), with a biological collection. This protocol allows to study all women at risk of PPH (Postpartum Hemorrhage) and postpartum venous thromboembolic disease, including maternity level 1-3 without case selection. The prospective nature of the study should provide a more detailed analysis of exposures in this particular population of women (risk factors related to the field, childbirth, the postpartum events ...). The events of interest were PPH and venous thromboembolic disease.

Enrollment

20,241 patients

Sex

Female

Ages

16+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Any woman giving birth and supported in one of Gynaecology Obstetrics services of a maternity Finistere.
  • Women ≥ 16 at the time of the collection of non-opposition.
  • For minor patients: understanding the patient and at least one parent.
  • All births ≥ 15 weeks gestation.

Exclusion criteria

  • Home Birth
  • Expressed opposition to participation in this study.
  • Childbirth under X.
  • Parent (s) uninformed of the pregnancy of their child.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems